- Nachrichtendetail
-
27.02.2024 13:14:46 - dpa-AFX: Ligand Pharmaceuticals Inc Q4 Earnings Summary
WASHINGTON (dpa-AFX) - Below are the earnings highlights for Ligand
Pharmaceuticals Inc (LGND):
Earnings: $18.19 million in Q4 vs. -$17.49 million in the same period last year.
EPS: $1.03 in Q4 vs. -$1.04 in the same period last year.
Excluding items, Ligand Pharmaceuticals Inc reported adjusted earnings of $24.41
million or $1.38 per share for the period.
Analysts projected $0.66 per share
Revenue: $28.10 million in Q4 vs. $50.38 million in the same period last year.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Pharmaceuticals Inc (LGND):
Earnings: $18.19 million in Q4 vs. -$17.49 million in the same period last year.
EPS: $1.03 in Q4 vs. -$1.04 in the same period last year.
Excluding items, Ligand Pharmaceuticals Inc reported adjusted earnings of $24.41
million or $1.38 per share for the period.
Analysts projected $0.66 per share
Revenue: $28.10 million in Q4 vs. $50.38 million in the same period last year.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
LIGAND PHARMAC.NEW DL-001 | A1C9RN | Frankfurt | 78,500 | 03.07.24 08:15:10 | ±0,000 | ±0,00% | 76,000 | 77,000 | 78,500 | 78,500 |
